3/20
12:11 pm
alny
Is Incyte Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Incyte Stock Outperforming the Dow? [Yahoo! Finance]
3/16
08:43 am
alny
Alnylam Pharmaceuticals (ALNY) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (ALNY) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.
3/13
05:30 am
alny
Amvuttra (Medison Pharma, Alnylam Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Amvuttra (Medison Pharma, Alnylam Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/12
07:39 am
alny
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]
Low
Report
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]
3/10
08:23 am
alny
Alnylam to Webcast TTR Investor Webinar [Yahoo! Finance]
Low
Report
Alnylam to Webcast TTR Investor Webinar [Yahoo! Finance]
3/10
08:00 am
alny
Alnylam to Webcast TTR Investor Webinar
Low
Report
Alnylam to Webcast TTR Investor Webinar
3/7
12:36 pm
alny
Alnylam Tenaya Cardiovascular RNAi Pact And What It Means For Valuation [Yahoo! Finance]
Low
Report
Alnylam Tenaya Cardiovascular RNAi Pact And What It Means For Valuation [Yahoo! Finance]
3/7
02:33 am
alny
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness [Yahoo! Finance]
3/6
05:14 pm
alny
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs [Yahoo! Finance]
Low
Report
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs [Yahoo! Finance]
3/6
07:32 am
alny
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]
Low
Report
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]
3/5
09:21 am
alny
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]
Low
Report
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]
3/5
09:18 am
alny
Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]
Low
Report
Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]
3/5
09:03 am
alny
Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]
Low
Report
Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]
3/4
06:48 pm
alny
Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]
Low
Report
Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]
3/2
11:52 pm
alny
Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]
3/2
04:12 pm
alny
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
04:34 am
alny
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics [Yahoo! Finance]
Low
Report
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics [Yahoo! Finance]
3/1
01:39 am
alny
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock [Yahoo! Finance]
Low
Report
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock [Yahoo! Finance]
2/28
07:02 pm
alny
Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? [Yahoo! Finance]
Low
Report
Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? [Yahoo! Finance]
2/23
10:25 am
alny
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
10:00 am
alny
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
Low
Report
Alnylam to Webcast Presentation at TD Cowen 46th Annual Health Care Conference
2/20
05:21 pm
alny
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge [Yahoo! Finance]
2/19
07:25 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
2/18
12:22 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
2/18
04:32 am
alny
Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models [Yahoo! Finance]
Low
Report
Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models [Yahoo! Finance]